Skip to Content

Neomycin Pregnancy and Breastfeeding Warnings

Neomycin is also known as: Mycifradin, Neo-Fradin, Neo-Tab

Neomycin Pregnancy Warnings

Neomycin has been assigned to pregnancy category D by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy; however, other aminoglycoside antibiotics cross the placenta. Streptomycin use in pregnancy has been associated with irreversible bilateral deafness in children. Serious fetal side effects have not been reported with other aminoglycosides. Patients should be warned of potential hazards to the fetus if they if take neomycin during pregnancy or become pregnant while taking this drug.

See references

Neomycin Breastfeeding Warnings

There are no data on the excretion of neomycin into human milk. Other aminoglycosides are excreted into human milk. The manufacturer recommends that due to the potential for adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Neomycin was excreted into cow milk after intramuscular injection.

See references

References for pregnancy information

  1. "Product Information. Neomycin (neomycin)" Pharma-Tek, Huntington, NY.

References for breastfeeding information

  1. "Product Information. Neomycin (neomycin)" Pharma-Tek, Huntington, NY.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.